CompaniesLaboratories Delalande

Laboratories Delalande

defunct
About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (2)
View all

Total Trials

2

As Lead Sponsor

0

As Collaborator

2

Total Enrollment

17,400

By Phase

NA: 2

By Status

WITHDRAWN: 1ENROLLING_BY_INVITATION: 1
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
2033
2034
2035
2036
2037
2038
Today
NCT03423303
Hover over trial bars to see details

Recent Trials

NCT03861468Collaborator
Medico-economics and QoL of Obese Patients Followed by Medical Analysis Laboratories (BIOSAOS )
NAWithdrawn
Started: Sep 14, 2019 · Completed: Dec 6, 2022
NCT03423303Collaborator
A Randomized Trial of Early Detection of Clinically Significant Prostate Cancer (ProScreen)
NAEnrolling by invitation
17,400 participants
Started: Apr 23, 2018 · Completed: Dec 31, 2037
Related Companies
Synthélabo
acquired